83 related articles for article (PubMed ID: 5666301)
1. [On the phthalides and 1,3-indaniones. XXIX. Preparation and anticoagulation activity of 2-phenyl-1,3-indandiones substituted in the position 5 of the indandione and in the position 4' of the phenyl nucleus].
Hrnciar P; Hrnciarová M; Kovalcík V
Cesk Farm; 1968 Mar; 17(3):118-21. PubMed ID: 5666301
[No Abstract] [Full Text] [Related]
2. [On the hypoprothrombinemic effect of 2-naphthoxyindandione-(1,3) and 2-tetrahydronaphthylindandiones-(1,3). 30. On the phthalides and indandiones].
Hrnciar P; Lácová M; Kovalcík V
Pharmazie; 1968 Sep; 23(9):499-500. PubMed ID: 5717188
[No Abstract] [Full Text] [Related]
3. Effect of anticoagulants on blood viscosity, circulation time and the capillaroscopic picture.
Pavlovskii DP
Fed Proc Transl Suppl; 1966; 25(2):367-9. PubMed ID: 4160513
[No Abstract] [Full Text] [Related]
4. Kinetics and mechanism of ionization of the carbon acids 4'-substituted 2-phenyl-1,3-indandiones.
Stella VJ; Gish R
J Pharm Sci; 1979 Aug; 68(8):1047-9. PubMed ID: 39157
[TBL] [Abstract][Full Text] [Related]
5. [Anticoagulant effect of 2-phenyl-1, 3-indandione].
POLIAK RIa
Farmakol Toksikol; 1955; 18(4):30-2. PubMed ID: 13262116
[No Abstract] [Full Text] [Related]
6. [Preparation of new indandione-analogues. 2. Phthalon analogues from diphenyl acid anhydride and methylpyridine- or methylquinoline derivatives].
Aleksiev B; Milosev M
Pharmazie; 1969 May; 24(5):291-2. PubMed ID: 5807385
[No Abstract] [Full Text] [Related]
7. Dipaxin: 2-diphenylacetyl-1,3-indandione; clinical evaluation of a new anticoagulant.
FIELD JB; GOLDFARB MS; WARE AG; GRIFFITH GC
Circulation; 1955 Apr; 11(4):576-83. PubMed ID: 14364732
[No Abstract] [Full Text] [Related]
8. Anticoagulant activities of some 2-acyl-1, 3-indandiones.
Bond HW; Dedhiya MG; Carlson GP
Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):288-91. PubMed ID: 4800265
[No Abstract] [Full Text] [Related]
9. [Polarographic properties of 2-aryl derivatives of 1,3-indandione. I. Microcoulometric evaluation of 2-phenyl-1,3-indandione by electroreduction in an alkaline medium].
DANEK A
Acta Pol Pharm; 1962; 19():345-9. PubMed ID: 14024881
[No Abstract] [Full Text] [Related]
10. Behaviour of 2-substituted 1,3-indandiones towards aldimines.
Afsah EM; Hamama WS; Etman HA; Sayed-Ahmed AF
Boll Chim Farm; 2001; 140(1):46-52. PubMed ID: 11338778
[TBL] [Abstract][Full Text] [Related]
11. [Effect of nucleophilic and electrophilic substitutes on the anticoagulant action of various 2-phenyl-1, 3-indandione derivatives].
CAVALLINI G; MILLA E; GRUMMELLI E; RAVENNA F
Farmaco Sci; 1955; 10(10):710-32. PubMed ID: 13294151
[No Abstract] [Full Text] [Related]
12. [Anticoagulant effect of 2-(4-bromo) phenyl-1, 3-indandione (fluidemin)].
BONO F; CORTINOVIS R
Minerva Chir; 1956 Oct; 11(19):949-52. PubMed ID: 13387072
[No Abstract] [Full Text] [Related]
13. Studies on the anticoagulant phenindione. IV. Its multiphasic effect on the coagulation mechanism.
ADAMIS D; KIMBALL D; SISE HS
J Lab Clin Med; 1957 Jan; 49(1):69-83. PubMed ID: 13385578
[No Abstract] [Full Text] [Related]
14. Levels of blood-coagulation factors during anticoagulant therapy with phenindione.
DENSON KW
Br Med J; 1961 Apr; 1(5234):1205-10. PubMed ID: 13721922
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administration.
de Vries J; Verboom CN; Groot EJ; Nauta WT; Wattel E
Eur J Drug Metab Pharmacokinet; 1979; 4(4):225-9. PubMed ID: 535602
[TBL] [Abstract][Full Text] [Related]
16. [Modification of an antitumor action of photodynamic therapy with anticoagulant drug fenylin].
Starosel'skaia AN; Ziablitskiĭ VM; Romanovskaia VN; Liubina LV; Mikhal'skaia TIu
Patol Fiziol Eksp Ter; 2007; (4):17-8. PubMed ID: 18159640
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary clinical investigations on a new indandione type anticoagulant: anisindione].
BALLERINI G; LA PAGLIA S
Prog Med (Napoli); 1959 Jan; 15(2):46-8. PubMed ID: 13658270
[No Abstract] [Full Text] [Related]
18. Anemia from sleep deprivation with anticoagulants in rats with enhancement by PCPA.
Drucker-Colín RR; Jaques LB; Cunningham TA
Pharmacol Biochem Behav; 1974; 2(6):817-26. PubMed ID: 4142808
[No Abstract] [Full Text] [Related]
19. Clinical experience with a new anticoagulant, dipaxin (2-diphenylacetyl-1,3-indandione).
PASCALE LR; OLWIN JH
Circulation; 1954 Feb; 9(2):230-7. PubMed ID: 13127184
[No Abstract] [Full Text] [Related]
20. [Drug information: coagulation inhibiting agents. II. Indirectly-acting anticoagulants. Coumarin derivatives: dicumarol, phenprocoumon (Marcoumar), warfarin (Marevan). Indandione derivatives: phenindione (Dindevan)].
Veje JO
Sygeplejersken; 1981 Jul; 81(28):10. PubMed ID: 6913187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
